Under the FDA-authorized expanded access (IND 176297), urcosimod is being provided by OKYO Pharma for use in a patient with severe neuropathic corneal pain who has limited therapeutic options and no ...
When an individual is involved in a personal injury incident, whether due to an accident, medical malpractice, or workplace negligence, the immediate focus often shifts to physical recovery. However, ...
ZyVersa Therapeutics, Inc. has announced the FDA-authorized Emergency Compassionate Use of its investigational drug VAR 200 for a patient with ApoCII amyloidosis, a rare kidney disease characterized ...
Forbes contributors publish independent expert analyses and insights. Laurel Donnellan is a compassion advocate focusing on leadership. This voice experience is generated by AI. Learn more. This voice ...
On October 17, 2025, the Chhattisgarh High Court ruled that a daughter can’t claim a compassionate appointment for her late mother’s job after 15 years. This judgement came from a case filed by one of ...
Can-Fite BioPharma's Namodenoson gains FDA approval for compassionate use in pancreatic cancer; Phase IIa trial underway in Israel. Can-Fite BioPharma Ltd. announced that major U.S. medical centers ...